Nvidia Invests $50M into AI Drug Discovery Firm Recursion
AI Chat: ChatGPT, AI News, Artificial Intelligence, OpenAI, Machine Learning
00:00
Recursion's $50 Million Investment in Nividia Could Pave the Way for Accelerated Drug Discovery
Nividia is a chip maker that uses machine learning to train drug discovery models. Recursion runs the recursion OS, an innovative platform providing critical data sets for pharma companies in designing and formulating new therapeutic drugs. Nividia plans to license these freshly minted models to biotech firms via bio Neo Mo, its new Gen. AI cloud service for drug discovery earlier this year.
Play episode from 06:00
Transcript
